|
1
|
Koo HM, Doh FM, Ko KI, Kim CH, Lee MJ, Oh
HJ, Han SH, Kim BS, Yoo TH, Kang SW and Choi KH: Diastolic
dysfunction is associated with an increased risk of
contrast-induced nephropathy: A retrospective cohort study. BMC
Nephrol. 14:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
James MT, Ghali WA, Tonelli M, Faris P,
Knudtson ML, Pannu N, Klarenbach SW, Manns BJ and Hemmelgarn BR:
Acute kidney injury following coronary angiography is associated
with a long-term decline in kidney function. Kidney Int.
78:803–809. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kelly AM, Dwamena B, Cronin P, Bernstein
SJ and Carlos RC: Meta-analysis: Effectiveness of drugs for
preventing contrast-induced nephropathy. Ann Intern Med.
148:284–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McCullough PA: Contrast-induced acute
kidney injury. J Am Coll Cardiol. 51:1419–1428. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
World Medical Association: World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. J Postgrad Med. 48:206–208.
2002.PubMed/NCBI
|
|
6
|
Solomon R: Contrast-induced acute kidney
injury (CIAKI). Radiol Clin North Am. 47:783–788. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mehran R, Aymong ED, Nikolsky E, Lasic Z,
Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al:
A simple risk score for prediction of contrast-induced nephropathy
after percutaneous coronary intervention: development and initial
validation. J Am Coll Cardiol. 44:1393–1399. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gault MH, Longerich LL, Harnett JD and
Wesolowski C: Predicting glomerular function from adjusted serum
creatinine. Nephron. 62:249–256. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toprak O: Conflicting and new risk factors
for contrast induced nephropathy. J Urol. 178:2277–2283. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davidson C, Stacul F, McCullough PA,
Tumlin J, Adam A, Lameire N and Becker CR: CIN Consensus Working
Panel: Contrast medium use. Am J Cardiol. 98:42K–58K. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reed M, Meier P, Tamhane UU, Welch KB,
Moscucci M and Gurm HS: The relative renal safety of iodixanol
compared with low-osmolar contrast media: A meta-analysis of
randomized controlled trials. JACC Cardiovasc Interv. 2:645–654.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mueller C, Buerkle G, Buettner HJ,
Petersen J, Perruchoud AP, Eriksson U, Marsch S and Roskamm H:
Prevention of contrast media-associated nephropathy: Randomized
comparison of 2 hydration regimens in 1620 patients undergoing
coronary angioplasty. Arch Intern Med. 162:329–336. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hogan SE, L'Allier P, Chetcuti S, Grossman
PM, Nallamothu BK, Duvernoy C, Bates E, Moscucci M and Gurm HS:
Current role of sodium bicarbonate-based preprocedural hydration
for the prevention of contrast-induced acute kidney injury: A
meta-analysis. Am Heart J. 156:414–421. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehran R and Nikolsky E: Contrast-induced
nephropathy: Definition, epidemiology and patients at risk. Kidney
Int Suppl. S11–S15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morcos SK: Prevention of contrast media
nephrotoxicity - the story so far. Clin Radiol. 59:381–389. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tanaka A, Ishii H, Sakakibara M, Okumura
S, Jinno Y, Okada K, Suzuki S, Inoue Y and Murohara T: Temporary
adjunctive cilostazol vs. clopidogrel loading for ST-segment
elevation acute myocardial infarction. Am J Cardiovasc Drugs.
14:131–136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SJ and Bang OY: Antiplatelet therapy
for preventing stroke in patients with chronic kidney disease.
Contrib Nephrol. 179:119–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harirforoosh S, Asghar W and Jamali F:
Adverse effects of nonsteroidal antiinflammatory drugs: An update
of gastrointestinal, cardiovascular and renal complications. J
Pharm Pharm Sci. 16:821–847. 2013.PubMed/NCBI
|
|
19
|
Harmon JP and Zimmerman DL and Zimmerman
DL: Anticoagulant and antiplatelet therapy in patients with chronic
kidney disease: Risks versus benefits review. Curr Opin Nephrol
Hypertens. 22:624–628. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Braam B, Joles JA, Danishwar AH and
Gaillard CA: Cardiorenal syndrome-current understanding and future
perspectives. Nat Rev Nephrol. 10:48–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shamseddin MK and Parfrey PS: Mechanisms
of the cardiorenal syndromes. Nat Rev Nephrol. 5:641–649. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Anand IS: Cardiorenal syndrome: A
cardiologist's perspective of pathophysiology. Clin J Am Soc
Nephrol. 8:1800–1807. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Clementi A, Virzi GM, Goh CY, Cruz DN,
Granata A, Vescovo G and Ronco C: Cardiorenal syndrome type 4: A
review. Cardiorenal Med. 3:63–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haller C and Hizoh I: The cytotoxicity of
iodinated radiocontrast agents on renal cells in vitro. Invest
Radiol. 39:149–154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heyman SN, Reichman J and Brezis M:
Pathophysiology of radiocontrast nephropathy: A role for medullary
hypoxia. Invest Radiol. 34:685–691. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liss P, Nygren A, Erikson U and Ulfendahl
HR: Injection of low and iso-osmolar contrast medium decreases
oxygen tension in the renal medulla. Kidney Int. 53:698–702. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deek H, Newton P, Sheerin N, Noureddine S
and Davidson PM: Contrast media induced nephropathy: A literature
review of the available evidence and recommendations for practice.
Aust Crit Care. 27:166–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
